Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candidosis

Loendersloot, E.W.

Gynakologische Rundschau 25(Suppl): 99-104

1985


ISSN/ISBN: 0017-6001
PMID: 4007627
Document Number: 444324
In a multicentre trial in Holland and Belgium a single-dose treatment with a 240-mg terconazole vaginal suppository proved as effective as a 3-day treatment with suppositories containing 80 mg terconazole or tablets containing 200 mg clotrimazole.

Document emailed within 1 workday
Secure & encrypted payments